Articles
 

HLA-G allele and Haplotype Frequencies in a Healthy Population of Iran

Abstract

The human leukocyte antigen (HLA)-G molecule is expressed in cytotrophoblast cells, adult thymic epithelial cells, erythroblasts, pancreatic islets and mesenchymal stem  cells. Although, HLA-G expression in allotransplanted patients is correlated with a better allograft acceptance, it is associated with an advanced grade of the tumor in cancer. In addition to the role on the immune system, HLA-G is also involved in successful pregnancy through the embryo implantation, fetal survival and the initial steps of hematopoiesis and angiogenesis.
The  aim of  this  study was determination  of  HLA-G  allele frequencies in a healthy population of Iran. In this research, we selected 100 samples from healthy Iranian individuals and henceforth, we used polymerase chain reaction (PCR) followed by sequencing technique for exon 2, 3, 4 and intron 2 of the gene for evaluating the HLA-G  alleles frequencies. Investigation of intronic (intron 2) variation is the  novelty of our study.
The obtained results indicated thirteen alleles of HLA-G in Iranian individuals including G*01:01:01:01, G*01:06, G*01:01:01:06, G*01:01:02, G*01:01:03, G*01:01:05, G*01:01:06, G*01:01:07, G*01:01:08, G*01:03, G*01:04:01, G*01:04:03, and G*01:04:04. According to this study, the most prevalent alleles in the Iranian population were G*01:01:01:01 (52.5%), G*01:01:02  (16%)  and  G*01:04:03  (14.5%) and  also  the  lowest  alleles regarding  the frequency were G*01:01:01:06 (0.5%) and G*01:03 (0.5%).
The results of G*01:01:01:01 and G*01:04:01 frequencies showed some similarities with the  polish population.  Our  results were similar to  the  north  Indian  population  for  the frequencies of G*01:06 and G*01:01:02.

1. Choudhury SR, Knapp LA. Human reproductive failure II: immunogenetic and interacting factors. Hum Reprod Update 2001; 7(2):135-60.
2. Carosella ED, Favier B, Rouas-Freiss N, Moreau P,Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008; 111(10):4862-70.
3. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 2011; 68(3):341-52.
4. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006; 12(3):209-32.
5. Rebmann V, Switala M, Eue I, Grosse-Wilde H.Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study. Hum Reprod 2010;25(7):1691-8.
6. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004; 104(10):3153-60.
7. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006; 103(44):16412-7.
8. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011; 68(3):369-95.
9. Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R. HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 2004; 65(1):39-46.
10. Onno M, Pangault C, Le Friec G, Guilloux V,Andre P, Fauchet R. Modulation of HLA-Gantigens expression by human cytomegalovirus:specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000; 164(12):6426-34.
11. Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M. Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. Aids 2004; 18(3):427-31.
12. Lajoie J, Hargrove J, Zijenah LS, Humphrey JH,Ward BJ, Roger M. Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 2006;193(2):298-301.
13. Kaneku H. Detection of soluble HLA-G and its correlation with kidney transplant outcome. Clin Transpl 2006:447-54.
14. Basturk B, Karakayali F, Emiroglu R, Sozer O, Haberal A, Bal D, et al. Human leukocyte antigen- G, a new parameter in the follow-up of liver transplantation. Transplantation proceedings. 2006;38(2):571-4.
15. Rebmann V, Bartsch D, Wunsch A, Mollenbeck P, Golda T, Viebahn R, et al. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol 2009; 70(12):995-9.
16. Crispim JC, Mendes-Junior CT, Wastowski IJ,Costa R, Castelli EC, Saber LT, et al. Frequency of insertion/deletion polymorphism in exon 8 of HLA- G and kidney allograft outcome. Tissue antigens 2008; 71(1):35-41.
17. Pirri A, Contieri FC, Benvenutti R, Bicalho Mda G.A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl Immunol 2009; 20(3):143-9.
18. Seliger B, Schlaf G. Structure, expression and function of HLA-G in renal cell carcinoma. Semin Cancer Biol 2007; 17(6):444-50.
19. Menier C, Prevot S, Carosella ED, Rouas-Freiss N.Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. Hum Immunol 2009; 70(12):1006-9.
20. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost ER. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 2006; 103(1):25-30.
21. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99(2):609-17.
22. Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006; 55(5):1214-22.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
24. Suarez MB, Morales P, Castro MJ, Fernandez V, Varela P, Alvarez M, et al. A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics 1997; 45(6):464-5.
25. Alvarez M, Santos P, Martinho A, Simoes O, Abade A, Breda-Coimbra H. HLA-G genetic polymorphism in 57 Portuguese white families studied by PCR-RFLP and PCR-SSOP. Transplant Proc 1999; 31(4):1829-31.
26. Castelli EC, Mendes-Junior CT, Donadi EA. HLA- G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue antigens 2007;70(1):62-8.
27. Ober C, Rosinsky B, Grimsley C, van der Ven K, Robertson A, Runge A. Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A1. J Reprod Immunol 1996; 32(2):111-23.
28. Park HJ, Kim MJ, Kang SW, Kim SK, Lee JS, Park HK, et al. Association between interleukin-4 gene polymorphisms and intracerebral haemorrhage in Korean population. Int J Immunogenet 2011; 38(4):321-5.
29. Karhukorpi J, Ikaheimo I, Silvennoinen-Kassinen S, Tiilikainen A. HLA-G polymorphism and allelic association with HLA-A in a Finnish population. Eur J Immunogenet 1996; 23(2):153-5.
30. Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004; 31(6):275-8.
31. Sipak-Szmigiel O, Cybulski C, Wokolorczyk D, Lubinski J, Kurzawa R, Baczkowski T, et al. HLA-G polymorphism and in vitro fertilization failure in a Polish population. Tissue antigens 2009; 73(4):348-52.
32. Lin A, Yan WH, Xu HH, Tang LJ, Chen XF, Zhu M, et al. 14 bp deletion polymorphism in the HLA- G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue antigens 2007; 70(5):427-31.
33. van der Ven K, Skrablin S, Engels G, Krebs D.HLA-G polymorphisms and allele frequencies in Caucasians. Hum Immunol 1998; 59(5):302-12.
34. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue antigens 2002; 60(2):122-32.
35. Hylenius S, Andersen AM, Melbye M, Hviid TV.Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004; 10(4):237-46.
36. Park Y, Park Y, Kim YS, Kwon OJ, Kim HS.Allele frequencies of human leukocyte antigen-G in a Korean population. Int J Immunogenet 2012;39(1):39-45.
37. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue antigens 2008;72(2):149-57.
38. Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev 2011;12(5):1323-7.

Files
IssueVol 13, No 3 (2014) QRcode
SectionArticles
Keywords
Allele frequency HLA-G Iranian Polymorphism Population

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kuroshli Z, Gourabi H, Bazrgar M, Sanati MH, Bahraminejad E, Anisi K. HLA-G allele and Haplotype Frequencies in a Healthy Population of Iran. Iran J Allergy Asthma Immunol. 1;13(3):207-213.